KRAS and non-small cell lung carcinoma: In a KRas-dependent model of spontaneous non-small-cell lung cancer (NSCLC), the inhibition of autophagy through ATG7 decreased tumor growth, converting adenomas and carcinomas into a benign disease characterized by the accumulation of defective mitochondria [110,111].